Wienemann, Tobias
Müller, Ann-Kristin
MacKenzie, Colin
Bielor, Carina
Weyers, Vivien
Aktas, Orhan
Hartung, Hans-Peter
Kremer, David
Article History
Received: 27 February 2020
Accepted: 21 April 2020
First Online: 27 April 2020
Ethics approval and consent to participate
: Not applicable.
: A written consent has been obtained from the patient for the publication of her course of disease as a case report in a peer-reviewed medical journal.
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: T.W., A.K.M, C.B., V.W. and C.M. have no disclosures. D.K. received compensation for speaking from Grifols SA. H.-P.H. received compensation for consulting, speaking, and serving on steering committees from Bayer Healthcare, Biogen, Celgene Receptos, GeNeuro, MedImmune, MedDay, Merck, Novartis, Roche, Sanofi Genzyme, and TG Therapeutics with approval by the Rector of Heinrich Heine University. Orhan Aktas has received grant support from Bayer, Biogen, Novartis, and Sanofi and consultancy or speaking fees and fees for serving on steering committees from Bayer, Biogen, Celgene, Medimmune, Merck, Novartis, Roche, Sanofi, and Teva.